pteridines has been researched along with xanthine in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (14.29) | 18.7374 |
| 1990's | 11 (39.29) | 18.2507 |
| 2000's | 8 (28.57) | 29.6817 |
| 2010's | 4 (14.29) | 24.3611 |
| 2020's | 1 (3.57) | 2.80 |
| Authors | Studies |
|---|---|
| Blankenship, PR; Bowyer, F; Hommes, FA; Roesel, RA | 1 |
| Johnson, JL; Mandell, R; Shih, VE; Wuebbens, MM | 1 |
| Archer, M; Engh, R; Hof, P; Huber, R; LeGall, J; Moura, I; Moura, JJ; Romão, MJ; Schneider, M | 1 |
| Mandel, H; Stroomer, LE; van Cruchten, AG; van Gennip, AH | 1 |
| Hille, R; Kim, JH; Knaut, H; Ryan, MG | 1 |
| Bray, RC; Burke, JF; Chovnick, A; Doyle, WA; Dutton, FL; Whittle, JR | 1 |
| Bellini, C; Bertola, A; Bonioli, E; Caruso, U; DiStefano, A; Dorche, C; Fantasia, AR; Minniti, G; Palmieri, A | 1 |
| Sumi, S; Wada, Y | 1 |
| Amaya, Y; Hosoya, T; Ichida, K; Kamatani, N; Nishino, T; Sakai, O | 1 |
| Hosoya, T; Ichida, K | 1 |
| Ishibashi, S; Matsuishi, T; Nakashima, M; Satoi, M | 1 |
| Grisham, MB; Koyama, S; Robbins, RA; Sato, E; Simpson, KL | 1 |
| Angermüller, S; Klipp, W; Leimkühler, S; Mendel, RR; Schwarz, G | 1 |
| Fujita, T; Ihara, N; Itoh, T; Sugimoto, Y; Watanabe, T | 1 |
| Jones, L; Kim, JH; Odutola, JA; Popham, J; von Laven, S | 1 |
| Adham, IM; Engel, W; Kneussel, M; Lee, HJ; Reiss, J; Sass, JO; Schwarz, G | 1 |
| Ichida, K | 2 |
| BROWN, GB; CRESSWELL, RM; MAURER, HK; STRAUSS, T | 1 |
| Al-Ahaidib, L; Al-Amoudi, M; Al-Shahwan, S; Eyaid, W; Jacob, M; Osman, ME; Rahbeeni, Z; Rashed, MS; Saadallah, AA; Salih, MA; Seidahmed, MZ | 1 |
| HOFSTEE, BH | 1 |
| Cao, H; Hille, R; Pauff, JM | 1 |
| Affandi, O; Afroze, B; Chen, BC; Ngu, LH; Zabedah, MY | 1 |
| Hwang, KC; Tai, LA | 1 |
| Kusano, T; Nishino, T; Okamoto, K | 1 |
| Nishino, T; Okamoto, K | 1 |
| Brueck, W; Burfeind, P; Hakroush, S; Jakubiczka-Smorag, J; Kumar, A; Metz, I; Reiss, J; Santamaria-Araujo, JA; Schwarz, G; Smorag, L | 1 |
| Agili, F; El-Kalyoubi, S | 1 |
7 review(s) available for pteridines and xanthine
| Article | Year |
|---|---|
[Xanthine oxidase deficiency (hereditary xanthinuria), molybdenum cofactor deficiency].
Topics: Central Nervous System Diseases; Coenzymes; Diagnosis, Differential; Diet Therapy; Humans; Infant, Newborn; Metalloproteins; Molybdenum Cofactors; Pteridines; Purine-Pyrimidine Metabolism, Inborn Errors; Seizures; Uric Acid; Xanthine; Xanthine Oxidase; Xanthines | 1996 |
[Classical xanthinuria (type I and II)].
Topics: Aldehyde Oxidase; Aldehyde Oxidoreductases; Coenzymes; Diagnosis, Differential; Humans; Metalloproteins; Molybdenum Cofactors; Mutation; Oxidoreductases Acting on Sulfur Group Donors; Prognosis; Pteridines; Purine-Pyrimidine Metabolism, Inborn Errors; Purines; Urinary Calculi; Xanthine; Xanthine Dehydrogenase | 1998 |
[Molybdenum cofactor deficiency].
Topics: Biomarkers; Coenzymes; Cysteine; Diagnosis, Differential; Female; Humans; Infant; Infant, Newborn; Male; Metal Metabolism, Inborn Errors; Metalloproteins; Molybdenum; Molybdenum Cofactors; Oxidoreductases Acting on Sulfur Group Donors; Pteridines; Sulfites; Xanthine | 1998 |
[Primary underproductive hypouricemia].
Topics: Allopurinol; Coenzymes; Diagnosis, Differential; Humans; Liver Diseases; Metalloproteins; Molybdenum Cofactors; Prognosis; Pteridines; Purine-Nucleoside Phosphorylase; Purine-Pyrimidine Metabolism, Inborn Errors; Ribose-Phosphate Pyrophosphokinase; Uric Acid; Xanthine | 2003 |
[Hereditary xanthinuria and molybdenum cofactor deficiency].
Topics: Coenzymes; Genes, Recessive; Humans; Metalloproteins; Molybdenum Cofactors; Mutation; Pteridines; Purine-Pyrimidine Metabolism, Inborn Errors; Uric Acid; Xanthine; Xanthine Dehydrogenase | 2003 |
Chemical nature and reaction mechanisms of the molybdenum cofactor of xanthine oxidoreductase.
Topics: Animals; Coenzymes; Drug Discovery; Electron Transport; Humans; Hydrogen Bonding; Hydroxylation; Metalloproteins; Models, Molecular; Molybdenum Cofactors; Nitric Oxide; Oxidation-Reduction; Protein Binding; Pteridines; Substrate Specificity; Uric Acid; Xanthine; Xanthine Dehydrogenase | 2013 |
Mechanistic insights into xanthine oxidoreductase from development studies of candidate drugs to treat hyperuricemia and gout.
Topics: Catalytic Domain; Coenzymes; Enzyme Inhibitors; Gout; Humans; Hyperuricemia; Metalloproteins; Molybdenum Cofactors; Pteridines; Xanthine; Xanthine Dehydrogenase | 2015 |
21 other study(ies) available for pteridines and xanthine
| Article | Year |
|---|---|
Combined xanthine and sulphite oxidase defect due to a deficiency of molybdenum cofactor.
Topics: Coenzymes; Humans; Infant, Newborn; Liver; Male; Metabolism, Inborn Errors; Metalloproteins; Molybdenum Cofactors; Oxidoreductases; Oxidoreductases Acting on Sulfur Group Donors; Pteridines; Sulfites; Xanthine; Xanthine Oxidase; Xanthines | 1986 |
Molybdenum cofactor deficiency in a patient previously characterized as deficient in sulfite oxidase.
Topics: Cells, Cultured; Coenzymes; Fibroblasts; Humans; Hypoxanthine; Hypoxanthines; Infant; Male; Metalloproteins; Molybdenum; Molybdenum Cofactors; Oxidoreductases; Oxidoreductases Acting on Sulfur Group Donors; Pteridines; Uric Acid; Xanthine; Xanthine Dehydrogenase; Xanthines | 1988 |
Crystal structure of the xanthine oxidase-related aldehyde oxido-reductase from D. gigas.
Topics: Aldehyde Oxidoreductases; Amino Acid Sequence; Animals; Coenzymes; Crystallization; Crystallography, X-Ray; Cytosine Nucleotides; Desulfovibrio; Drosophila melanogaster; Electron Transport; Hydrogen Bonding; Iron; Ligands; Metalloproteins; Molecular Sequence Data; Molybdenum; Molybdenum Cofactors; Oxidation-Reduction; Protein Conformation; Protein Folding; Protein Structure, Secondary; Pteridines; Pterins; Xanthine; Xanthine Oxidase; Xanthines | 1995 |
Effect of allopurinol on the xanthinuria in a patient with molybdenum cofactor deficiency.
Topics: Allopurinol; Coenzymes; Female; Humans; Male; Metabolism, Inborn Errors; Metalloproteins; Molybdenum; Molybdenum Cofactors; Pteridines; Purine-Pyrimidine Metabolism, Inborn Errors; Xanthine; Xanthine Dehydrogenase; Xanthines | 1994 |
The reductive half-reaction of xanthine oxidase. The involvement of prototropic equilibria in the course of the catalytic sequence.
Topics: Catalysis; Electron Spin Resonance Spectroscopy; Fluorescent Dyes; Hydrogen-Ion Concentration; Kinetics; Molybdenum; Oxidation-Reduction; Pteridines; Purines; Solvents; Substrate Specificity; Xanthine; Xanthine Oxidase; Xanthines | 1996 |
Properties of xanthine dehydrogenase variants from rosy mutant strains of Drosophila melanogaster and their relevance to the enzyme's structure and mechanism.
Topics: Amino Acid Sequence; Animals; Binding Sites; Coenzymes; Conserved Sequence; Cross Reactions; Drosophila melanogaster; Enzyme Activation; Genetic Variation; Kinetics; Metalloproteins; Molecular Sequence Data; Molybdenum Cofactors; Mutagenesis, Site-Directed; Mutation; NAD; Oxidation-Reduction; Pteridines; Sequence Homology, Amino Acid; Structure-Activity Relationship; Xanthine; Xanthine Dehydrogenase; Xanthines | 1996 |
Combined deficiency of xanthine oxidase and sulphite oxidase due to a deficiency of molybdenum cofactor.
Topics: Coenzymes; Female; Fibroblasts; Humans; Hypoxanthine; Infant; Metabolism, Inborn Errors; Metalloproteins; Molybdenum; Molybdenum Cofactors; Nervous System Diseases; Oxidoreductases Acting on Sulfur Group Donors; Pteridines; Uric Acid; Xanthine; Xanthine Oxidase; Xanthines | 1996 |
Identification of two mutations in human xanthine dehydrogenase gene responsible for classical type I xanthinuria.
Topics: Adult; Aged; Codon; Coenzymes; DNA Primers; Duodenum; Humans; Intestinal Mucosa; Male; Metalloproteins; Molybdenum; Molybdenum Cofactors; Point Mutation; Polymerase Chain Reaction; Pteridines; Purine-Pyrimidine Metabolism, Inborn Errors; RNA, Messenger; Sequence Deletion; Xanthine; Xanthine Dehydrogenase; Xanthines | 1997 |
Effects of reactive oxygen and nitrogen metabolites on RANTES- and IL-5-induced eosinophil chemotactic activity in vitro.
Topics: Chemokine CCL5; Chemotaxis; Deferoxamine; Dithiothreitol; Dose-Response Relationship, Drug; Eosinophils; Humans; Hydrazines; Interleukin-5; Leukotriene B4; Molsidomine; Nitrates; Nitric Oxide; Nitrogen; Pteridines; Reactive Oxygen Species; Superoxides; Tyrosine; Xanthine | 1999 |
Activity of the molybdopterin-containing xanthine dehydrogenase of Rhodobacter capsulatus can be restored by high molybdenum concentrations in a moeA mutant defective in molybdenum cofactor biosynthesis.
Topics: Amino Acid Sequence; Coenzymes; DNA Mutational Analysis; Escherichia coli; Escherichia coli Proteins; Eukaryotic Cells; Guanine Nucleotides; Iron-Sulfur Proteins; Metalloproteins; Models, Biological; Molecular Sequence Data; Molybdenum; Molybdenum Cofactors; Mutagenesis, Insertional; Mutation; Nitrate Reductases; Organometallic Compounds; Oxidoreductases; Pteridines; Rhodobacter capsulatus; Sequence Homology, Amino Acid; Sulfurtransferases; Xanthine; Xanthine Oxidase | 1999 |
Deletion mutation in Drosophila ma-l homologous, putative molybdopterin cofactor sulfurase gene is associated with bovine xanthinuria type II.
Topics: Amino Acid Sequence; Animals; Cattle; Cattle Diseases; Coenzymes; Drosophila; Genes, Insect; Metalloproteins; Molecular Sequence Data; Molybdenum Cofactors; Pteridines; Sequence Deletion; Sequence Homology, Amino Acid; Xanthine; Xanthine Dehydrogenase | 2000 |
Tautomeric energetics of xanthine oxidase substrates: xanthine, 2-oxo-6-methylpurine, and lumazine.
Topics: Catalysis; Energy Metabolism; In Vitro Techniques; Isomerism; Pteridines; Purines; Quantum Theory; Substrate Specificity; Thermodynamics; Xanthine; Xanthine Oxidase | 2001 |
Molybdenum cofactor-deficient mice resemble the phenotype of human patients.
Topics: Animals; Carbon-Carbon Lyases; Coenzymes; Disease Models, Animal; Humans; Metalloproteins; Mice; Mice, Transgenic; Molybdenum Cofactors; Nuclear Proteins; Pteridines; Sulfites; Uric Acid; Xanthine; Xanthine Dehydrogenase | 2002 |
PURINE N-OXIDES. XIV. A TOTAL SYNTHESIS OF A PYRIMIDINE N-OXIDE, A PTERIDINE 1-N-OXIDE, AND XANTHINE 3-N-OXIDE.
Topics: Chemical Phenomena; Chemistry; Oxides; Pteridines; Pterins; Purines; Pyrimidines; Research; Xanthine; Xanthines | 1965 |
Determination of urinary S-sulphocysteine, xanthine and hypoxanthine by liquid chromatography-electrospray tandem mass spectrometry.
Topics: Adult; Brain Diseases, Metabolic, Inborn; Child; Child, Preschool; Chromatography, Liquid; Coenzymes; Cysteine; Humans; Hypoxanthine; Infant; Infant, Newborn; Metalloproteins; Molybdenum Cofactors; Oxidoreductases Acting on Sulfur Group Donors; Pteridines; Spectrometry, Mass, Electrospray Ionization; Xanthine | 2005 |
Inhibition of the enzymic oxidation of xanthine and xanthopterin by pteridines.
Topics: Oxidation-Reduction; Pteridines; Xanthine; Xanthines; Xanthopterin | 1949 |
Substrate Orientation and Catalysis at the Molybdenum Site in Xanthine Oxidase: CRYSTAL STRUCTURES IN COMPLEX WITH XANTHINE AND LUMAZINE.
Topics: Animals; Bacterial Proteins; Catalysis; Catalytic Domain; Cattle; Crystallography, X-Ray; Female; Milk; Molybdenum; Protein Structure, Tertiary; Pteridines; Rhodobacter capsulatus; Xanthine; Xanthine Oxidase | 2009 |
Molybdenum cofactor deficiency in a Malaysian child.
Topics: Brain Diseases; Child; Coenzymes; Cysteine; Diagnosis, Differential; Humans; Hypoxanthine; Hypoxia; Ischemia; Malaysia; Male; Metalloproteins; Molybdenum Cofactors; Pteridines; Sulfites; Uric Acid; Xanthine | 2009 |
Regulation of xanthine oxidase activity by substrates at active sites via cooperative interactions between catalytic subunits: implication to drug pharmacokinetics.
Topics: Adenine; Binding Sites; Catalysis; Catalytic Domain; Dimerization; Enzyme Inhibitors; Humans; Models, Theoretical; Protein Binding; Pteridines; Pterins; Substrate Specificity; Xanthine; Xanthine Oxidase; Xanthopterin | 2011 |
Mouse model for molybdenum cofactor deficiency type B recapitulates the phenotype observed in molybdenum cofactor deficient patients.
Topics: Animals; Apoptosis; Carbon-Carbon Lyases; Coenzymes; Cysteine; Disease Models, Animal; Gene Expression; Humans; Hypoxanthine; Metal Metabolism, Inborn Errors; Metalloproteins; Mice; Mice, Knockout; Molybdenum Cofactors; Mutation; Nuclear Proteins; Phenotype; Pteridines; Xanthine | 2016 |
Synthesis, In Silico Prediction and In Vitro Evaluation of Antitumor Activities of Novel Pyrido[2,3-
Topics: A549 Cells; Antineoplastic Agents; Binding Sites; Chemistry Techniques, Synthetic; Cyclin-Dependent Kinase 2; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Folic Acid; Humans; Inhibitory Concentration 50; Janus Kinase 2; MCF-7 Cells; Molecular Docking Simulation; Neoplasms; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-mdm2; Pteridines; Pyridines; Pyrimidines; Tetrahydrofolate Dehydrogenase; Tumor Suppressor Protein p53; Xanthine | 2020 |